Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people starting Wegovy (semaglutide) for weight loss focus on the number on the scale. Fewer think about what that number is made of. Building muscle on Wegovy is possible, but it takes deliberate effort: weight loss from any source can reduce lean mass alongside fat, so the steps you take during treatment shape the quality of the result. These are prescription-only medicines — a prescriber assesses your suitability before treatment begins — but the lifestyle work is yours to do, and it starts before your first dose.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first few weeks of Wegovy are when nausea and reduced hunger are most noticeable. That is precisely the wrong time to work out your nutrition habits. Get ahead of it.
Current UK clinical guidance, summarised by the NHS semaglutide medicines page, emphasises the importance of a balanced diet alongside treatment. For muscle retention specifically, protein is the lever that matters most. A general target used in weight-management practice is around 1.2–1.6 g of protein per kilogram of body weight per day; your prescriber or a registered dietitian can personalise this based on your starting weight and activity level.
In practice, many people on GLP-1 treatment find they can hit that target with two or three protein-anchored meals rather than grazing. A quick habit worth building: weigh or estimate the protein in your first meal of the day. If it reaches 30–40 g before 10am, the rest of the day is easier to manage. Do that check for the first week and it tends to stick. Eggs, Greek yoghurt, chicken, fish, legumes and cottage cheese all work well because they are satiating without large volumes, relevant when your appetite is already reduced.
One thing to avoid: letting nausea become a reason to skip protein-dense foods entirely. Bland, carbohydrate-heavy foods are easier to tolerate when you feel queasy, but leaning on them too hard for too long accelerates muscle loss. Small, frequent portions of protein-rich food often tolerate better than a large serving.
Cardio burns calories. Resistance training sends the signal that your body should keep (and ideally build) muscle tissue. During a calorie deficit, that signal is the only reason your body has to preserve lean mass rather than use it for fuel.
You do not need to train like a bodybuilder. Two to three sessions per week involving compound movements (squats, deadlifts, rows, press-ups or their gym equivalents) is sufficient to generate the anabolic stimulus that protects muscle during weight loss. NHS England's clinical guidance on weight-management injections consistently highlights increased physical activity as a core component of treatment, resistance work is the most targeted form of that activity for this purpose.
If you are new to resistance training, start with bodyweight exercises or light loads and focus on form. The muscle-protective effect comes from progressive challenge over weeks and months, not from lifting heavy immediately. Soreness in the first fortnight is normal. Giving up in the first fortnight is common. The people who preserve the most lean mass during GLP-1 treatment tend to be the ones who treat their training sessions as appointments, not options.
Concerns about muscle loss on semaglutide are worth reading about separately, the dedicated page on Wegovy and muscle loss covers what the evidence actually shows about lean mass changes during treatment. For those who want to go further, the guidance on how to build muscle on Wegovy sets out practical strategies for making progress rather than just limiting losses.
Faster is not always better. Losing 1–1.5 kg per week consistently tends to remove more lean tissue proportionally than a slower, steadier trajectory. Semaglutide's dose-escalation schedule helps here: the titration from 0.25 mg upward over several months is designed partly for tolerability, but it also means weight loss tends to accelerate gradually rather than dramatically from week one.
Keep your clinical review appointments. A prescriber who can see your progress over time (not just a snapshot) is better placed to adjust the pace of treatment if lean-mass concerns arise. At nume, every repeat order goes through a fresh clinical review by a GPhC-registered prescriber, which means changes in how you are responding to treatment are picked up systematically rather than left to chance.
Sleep is often the forgotten third variable. Muscle protein synthesis is highest during deep sleep; chronic sleep deprivation while in a calorie deficit significantly worsens lean-mass outcomes. Most adults need 7–9 hours. If you are struggling with sleep quality during treatment (sometimes nausea or GI discomfort interrupts sleep early in the titration) mention it at your review.
If you are weighing up semaglutide against tirzepatide (Mounjaro), the semaglutide overview page and the full Wegovy treatment page cover the clinical comparison in more detail. Anyone with a specific interest in performance and body composition can also find detailed information on semaglutide body building approaches, covering how the medicine interacts with training goals. And if cost is a factor in your decision-making, the cost context page for Wegovy in the UK explains what private treatment typically involves beyond the headline figure.
These are prescription medicines. Muscle-building strategies sit alongside treatment, not instead of clinical oversight. If you would like to explore whether Wegovy is suitable for you, check your eligibility through a free consultation, a prescriber, not a system, reviews your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.